News & Events
-
September 17, 2021 - September 23, 2022
Movement Disorders Congress 2021 | Presentations on behalf of CPP
Critical Path for Parkinson’s members, advisors and staff submitted six posters on behalf of CPP and CPP’s digital effort, Digital Drug Development Tools (3DT), to MDS Virtual Congress 2021. All abstracts are available here. Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium (abstract #341) Martijn Muller1,...... -
May 19, 2021 - May 20, 2021
2021 PKD Regulatory Summit
Join C-Path’s PKDOC and The PKD Foundation for the 2021 PKD Regulatory Summit on May 19 and 20. Together with key stakeholders from around the world, the consortium will address current unmet drug development needs for PKD, identify tools that are needed to deliver new therapies to patients, and catalyze the development of a regulatory framework to enable advancement of new treatments.
-
May 7, 2021
VIEW NOW: COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop
The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual workshop on COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials held on May 7, 2021. Objectives for the workshop included: Identifying challenges to conducting pediatric rare disease clinical trials posed by COVID-19 Presenting a range of strategies...... -
April 14, 2021 - April 15, 2021
View Now: 12th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually
April 14–15, 2021 On April 14–15, 2021, the 12th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual format. The following Workshop Agenda provides an overview of the two-day meeting as well as links to the session recordings and slide decks. Links to posters summarizing the status of the PRO Consortium’s working groups, the Rare Disease...... -
April 29, 2020 - May 6, 2020
CANCELLED: 2020 Pediatric Academic Societies Meeting – International Stakeholder Collaboration to Develop Neonatal Therapeutics: How to Play Well in the Global Sandbox
C-Path’s International Neonatal Consortium (INC) will host a panel discussion at the 2020 Pediatric Academic Societies Meeting in Philadelphia, Saturday, May 2, titled, “International Stakeholder Collaboration to Develop Neonatal Therapeutics: How to Play Well in the Global Sandbox.” INC convenes academic experts, regulators, nurses, industry sponsor and patient/parent advocates from across the globe to forge a predictable regulatory path for evaluating the safety and effectiveness of therapies for neonates. More information…